Artemis Medicare to manage 650-bed VIMHANS Hospital in Rs. 520 South Delhi expansion
The project entails a total planned capital expenditure of approximately Rs. 500 - 520 crore
The project entails a total planned capital expenditure of approximately Rs. 500 - 520 crore
BLA is based on a robust data package supporting similarity to Orencia (abatacept) IV for infusion through totality of evidence including pharmacokinetic (PK) data
Net sales reached CHF 1,327.8 million, up 2.6% year-on-year in Swiss francs, or 4.3% at constant exchange rates
Both non-transfusion-dependent and transfusion dependent cohorts met their respective primary and secondary endpoints
The agreement will see the two companies jointly develop and commercialise premium nutraceutical ingredients in advanced transdermal delivery formats
Acquisition expands Axol’s portfolio of iPSC-derived retinal organoid and retinal pigment epithelium (RPE) models
40+ most innovative startups with disruptive contributions across MedTech, Medical Devices, BioPharma, Cell and Gene Therapy, AI and ML, Nutraceuticals, and Biomarkers exhibited their cutting-edge solutions
ANYRA is India’s first indigenously developed Aflibercept 2 mg biosimilar
The data highlights its RSV vaccine cuts hospitalizations in older adults
Subscribe To Our Newsletter & Stay Updated